Medical Care
Global Pediatric Orphan Drugs Market Research Report 2025
- Mar 11, 25
- ID: 14178
- Pages: 89
- Figures: 81
- Views: 2
The global market for Pediatric Orphan Drugs was valued at US$ 61430 million in the year 2024 and is projected to reach a revised size of US$ 122400 million by 2031, growing at a CAGR of 10.5% during the forecast period.
Pediatric orphan drugs are medications that are specifically developed and approved for the treatment of rare diseases or conditions in children. These drugs are designed to address medical needs in pediatric populations who have limited treatment options due to the rarity of their conditions. Pediatric orphan drugs are vital in addressing the unique medical needs of children with rare diseases and improving their health outcomes and quality of life.
According to our “ Pharma & Healthcare Research Center” statistics, the global sales of Orphan Drugs reached $139170 million in 2022. The North America region was the world largest Orphan Drugs market, accounting for 40% of Orphan Drugs sales in 2022, followed by Asia-Pacific. The global market for pediatric orphan drugs has been growing steadily in recent years due to increasing awareness of rare pediatric diseases, advancements in medical research and technology, and improved regulatory support for pediatric drug development.
This report aims to provide a comprehensive presentation of the global market for Pediatric Orphan Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Orphan Drugs.
The Pediatric Orphan Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Orphan Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Orphan Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Recordati SpA
Novartis
Celgene
Abbvie
Orpharma
Amgen
Amryt Pharma Plc.
Johnson & Johnson
GSK
Bristol-Myers Squibb Company
Roche Holding
Pfizer
Sanofi
Takeda
Segment by Type
Oncology Drugs
Gastrointestinal Drugs
Neurology Drugs
Cardio-vascular Drugs
Others
Segment by Application
Hospital Pharmacies
Retail pharmacies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Orphan Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pediatric orphan drugs are medications that are specifically developed and approved for the treatment of rare diseases or conditions in children. These drugs are designed to address medical needs in pediatric populations who have limited treatment options due to the rarity of their conditions. Pediatric orphan drugs are vital in addressing the unique medical needs of children with rare diseases and improving their health outcomes and quality of life.
According to our “ Pharma & Healthcare Research Center” statistics, the global sales of Orphan Drugs reached $139170 million in 2022. The North America region was the world largest Orphan Drugs market, accounting for 40% of Orphan Drugs sales in 2022, followed by Asia-Pacific. The global market for pediatric orphan drugs has been growing steadily in recent years due to increasing awareness of rare pediatric diseases, advancements in medical research and technology, and improved regulatory support for pediatric drug development.
This report aims to provide a comprehensive presentation of the global market for Pediatric Orphan Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Orphan Drugs.
The Pediatric Orphan Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Orphan Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Orphan Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Recordati SpA
Novartis
Celgene
Abbvie
Orpharma
Amgen
Amryt Pharma Plc.
Johnson & Johnson
GSK
Bristol-Myers Squibb Company
Roche Holding
Pfizer
Sanofi
Takeda
Segment by Type
Oncology Drugs
Gastrointestinal Drugs
Neurology Drugs
Cardio-vascular Drugs
Others
Segment by Application
Hospital Pharmacies
Retail pharmacies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Orphan Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Orphan Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oncology Drugs
1.2.3 Gastrointestinal Drugs
1.2.4 Neurology Drugs
1.2.5 Cardio-vascular Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Pediatric Orphan Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Orphan Drugs Market Perspective (2020-2031)
2.2 Global Pediatric Orphan Drugs Growth Trends by Region
2.2.1 Global Pediatric Orphan Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pediatric Orphan Drugs Historic Market Size by Region (2020-2025)
2.2.3 Pediatric Orphan Drugs Forecasted Market Size by Region (2026-2031)
2.3 Pediatric Orphan Drugs Market Dynamics
2.3.1 Pediatric Orphan Drugs Industry Trends
2.3.2 Pediatric Orphan Drugs Market Drivers
2.3.3 Pediatric Orphan Drugs Market Challenges
2.3.4 Pediatric Orphan Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Orphan Drugs Players by Revenue
3.1.1 Global Top Pediatric Orphan Drugs Players by Revenue (2020-2025)
3.1.2 Global Pediatric Orphan Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Pediatric Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Orphan Drugs Revenue
3.4 Global Pediatric Orphan Drugs Market Concentration Ratio
3.4.1 Global Pediatric Orphan Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Orphan Drugs Revenue in 2024
3.5 Global Key Players of Pediatric Orphan Drugs Head office and Area Served
3.6 Global Key Players of Pediatric Orphan Drugs, Product and Application
3.7 Global Key Players of Pediatric Orphan Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Orphan Drugs Breakdown Data by Type
4.1 Global Pediatric Orphan Drugs Historic Market Size by Type (2020-2025)
4.2 Global Pediatric Orphan Drugs Forecasted Market Size by Type (2026-2031)
5 Pediatric Orphan Drugs Breakdown Data by Application
5.1 Global Pediatric Orphan Drugs Historic Market Size by Application (2020-2025)
5.2 Global Pediatric Orphan Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pediatric Orphan Drugs Market Size (2020-2031)
6.2 North America Pediatric Orphan Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pediatric Orphan Drugs Market Size by Country (2020-2025)
6.4 North America Pediatric Orphan Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Orphan Drugs Market Size (2020-2031)
7.2 Europe Pediatric Orphan Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pediatric Orphan Drugs Market Size by Country (2020-2025)
7.4 Europe Pediatric Orphan Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Orphan Drugs Market Size (2020-2031)
8.2 Asia-Pacific Pediatric Orphan Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Orphan Drugs Market Size (2020-2031)
9.2 Latin America Pediatric Orphan Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pediatric Orphan Drugs Market Size by Country (2020-2025)
9.4 Latin America Pediatric Orphan Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Orphan Drugs Market Size (2020-2031)
10.2 Middle East & Africa Pediatric Orphan Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recordati SpA
11.1.1 Recordati SpA Company Details
11.1.2 Recordati SpA Business Overview
11.1.3 Recordati SpA Pediatric Orphan Drugs Introduction
11.1.4 Recordati SpA Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.1.5 Recordati SpA Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Pediatric Orphan Drugs Introduction
11.2.4 Novartis Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Pediatric Orphan Drugs Introduction
11.3.4 Celgene Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.3.5 Celgene Recent Development
11.4 Abbvie
11.4.1 Abbvie Company Details
11.4.2 Abbvie Business Overview
11.4.3 Abbvie Pediatric Orphan Drugs Introduction
11.4.4 Abbvie Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.4.5 Abbvie Recent Development
11.5 Orpharma
11.5.1 Orpharma Company Details
11.5.2 Orpharma Business Overview
11.5.3 Orpharma Pediatric Orphan Drugs Introduction
11.5.4 Orpharma Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.5.5 Orpharma Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Pediatric Orphan Drugs Introduction
11.6.4 Amgen Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Amryt Pharma Plc.
11.7.1 Amryt Pharma Plc. Company Details
11.7.2 Amryt Pharma Plc. Business Overview
11.7.3 Amryt Pharma Plc. Pediatric Orphan Drugs Introduction
11.7.4 Amryt Pharma Plc. Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.7.5 Amryt Pharma Plc. Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Pediatric Orphan Drugs Introduction
11.8.4 Johnson & Johnson Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.8.5 Johnson & Johnson Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Pediatric Orphan Drugs Introduction
11.9.4 GSK Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.9.5 GSK Recent Development
11.10 Bristol-Myers Squibb Company
11.10.1 Bristol-Myers Squibb Company Company Details
11.10.2 Bristol-Myers Squibb Company Business Overview
11.10.3 Bristol-Myers Squibb Company Pediatric Orphan Drugs Introduction
11.10.4 Bristol-Myers Squibb Company Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.10.5 Bristol-Myers Squibb Company Recent Development
11.11 Roche Holding
11.11.1 Roche Holding Company Details
11.11.2 Roche Holding Business Overview
11.11.3 Roche Holding Pediatric Orphan Drugs Introduction
11.11.4 Roche Holding Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.11.5 Roche Holding Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Pediatric Orphan Drugs Introduction
11.12.4 Pfizer Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.12.5 Pfizer Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Pediatric Orphan Drugs Introduction
11.13.4 Sanofi Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.13.5 Sanofi Recent Development
11.14 Takeda
11.14.1 Takeda Company Details
11.14.2 Takeda Business Overview
11.14.3 Takeda Pediatric Orphan Drugs Introduction
11.14.4 Takeda Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.14.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Orphan Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oncology Drugs
1.2.3 Gastrointestinal Drugs
1.2.4 Neurology Drugs
1.2.5 Cardio-vascular Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Pediatric Orphan Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Orphan Drugs Market Perspective (2020-2031)
2.2 Global Pediatric Orphan Drugs Growth Trends by Region
2.2.1 Global Pediatric Orphan Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pediatric Orphan Drugs Historic Market Size by Region (2020-2025)
2.2.3 Pediatric Orphan Drugs Forecasted Market Size by Region (2026-2031)
2.3 Pediatric Orphan Drugs Market Dynamics
2.3.1 Pediatric Orphan Drugs Industry Trends
2.3.2 Pediatric Orphan Drugs Market Drivers
2.3.3 Pediatric Orphan Drugs Market Challenges
2.3.4 Pediatric Orphan Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Orphan Drugs Players by Revenue
3.1.1 Global Top Pediatric Orphan Drugs Players by Revenue (2020-2025)
3.1.2 Global Pediatric Orphan Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Pediatric Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Orphan Drugs Revenue
3.4 Global Pediatric Orphan Drugs Market Concentration Ratio
3.4.1 Global Pediatric Orphan Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Orphan Drugs Revenue in 2024
3.5 Global Key Players of Pediatric Orphan Drugs Head office and Area Served
3.6 Global Key Players of Pediatric Orphan Drugs, Product and Application
3.7 Global Key Players of Pediatric Orphan Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Orphan Drugs Breakdown Data by Type
4.1 Global Pediatric Orphan Drugs Historic Market Size by Type (2020-2025)
4.2 Global Pediatric Orphan Drugs Forecasted Market Size by Type (2026-2031)
5 Pediatric Orphan Drugs Breakdown Data by Application
5.1 Global Pediatric Orphan Drugs Historic Market Size by Application (2020-2025)
5.2 Global Pediatric Orphan Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pediatric Orphan Drugs Market Size (2020-2031)
6.2 North America Pediatric Orphan Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pediatric Orphan Drugs Market Size by Country (2020-2025)
6.4 North America Pediatric Orphan Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Orphan Drugs Market Size (2020-2031)
7.2 Europe Pediatric Orphan Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pediatric Orphan Drugs Market Size by Country (2020-2025)
7.4 Europe Pediatric Orphan Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Orphan Drugs Market Size (2020-2031)
8.2 Asia-Pacific Pediatric Orphan Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Orphan Drugs Market Size (2020-2031)
9.2 Latin America Pediatric Orphan Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pediatric Orphan Drugs Market Size by Country (2020-2025)
9.4 Latin America Pediatric Orphan Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Orphan Drugs Market Size (2020-2031)
10.2 Middle East & Africa Pediatric Orphan Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recordati SpA
11.1.1 Recordati SpA Company Details
11.1.2 Recordati SpA Business Overview
11.1.3 Recordati SpA Pediatric Orphan Drugs Introduction
11.1.4 Recordati SpA Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.1.5 Recordati SpA Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Pediatric Orphan Drugs Introduction
11.2.4 Novartis Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Pediatric Orphan Drugs Introduction
11.3.4 Celgene Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.3.5 Celgene Recent Development
11.4 Abbvie
11.4.1 Abbvie Company Details
11.4.2 Abbvie Business Overview
11.4.3 Abbvie Pediatric Orphan Drugs Introduction
11.4.4 Abbvie Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.4.5 Abbvie Recent Development
11.5 Orpharma
11.5.1 Orpharma Company Details
11.5.2 Orpharma Business Overview
11.5.3 Orpharma Pediatric Orphan Drugs Introduction
11.5.4 Orpharma Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.5.5 Orpharma Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Pediatric Orphan Drugs Introduction
11.6.4 Amgen Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Amryt Pharma Plc.
11.7.1 Amryt Pharma Plc. Company Details
11.7.2 Amryt Pharma Plc. Business Overview
11.7.3 Amryt Pharma Plc. Pediatric Orphan Drugs Introduction
11.7.4 Amryt Pharma Plc. Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.7.5 Amryt Pharma Plc. Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Pediatric Orphan Drugs Introduction
11.8.4 Johnson & Johnson Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.8.5 Johnson & Johnson Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Pediatric Orphan Drugs Introduction
11.9.4 GSK Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.9.5 GSK Recent Development
11.10 Bristol-Myers Squibb Company
11.10.1 Bristol-Myers Squibb Company Company Details
11.10.2 Bristol-Myers Squibb Company Business Overview
11.10.3 Bristol-Myers Squibb Company Pediatric Orphan Drugs Introduction
11.10.4 Bristol-Myers Squibb Company Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.10.5 Bristol-Myers Squibb Company Recent Development
11.11 Roche Holding
11.11.1 Roche Holding Company Details
11.11.2 Roche Holding Business Overview
11.11.3 Roche Holding Pediatric Orphan Drugs Introduction
11.11.4 Roche Holding Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.11.5 Roche Holding Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Pediatric Orphan Drugs Introduction
11.12.4 Pfizer Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.12.5 Pfizer Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Pediatric Orphan Drugs Introduction
11.13.4 Sanofi Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.13.5 Sanofi Recent Development
11.14 Takeda
11.14.1 Takeda Company Details
11.14.2 Takeda Business Overview
11.14.3 Takeda Pediatric Orphan Drugs Introduction
11.14.4 Takeda Revenue in Pediatric Orphan Drugs Business (2020-2025)
11.14.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pediatric Orphan Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oncology Drugs
Table 3. Key Players of Gastrointestinal Drugs
Table 4. Key Players of Neurology Drugs
Table 5. Key Players of Cardio-vascular Drugs
Table 6. Key Players of Others
Table 7. Global Pediatric Orphan Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pediatric Orphan Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Pediatric Orphan Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Pediatric Orphan Drugs Market Share by Region (2020-2025)
Table 11. Global Pediatric Orphan Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Pediatric Orphan Drugs Market Share by Region (2026-2031)
Table 13. Pediatric Orphan Drugs Market Trends
Table 14. Pediatric Orphan Drugs Market Drivers
Table 15. Pediatric Orphan Drugs Market Challenges
Table 16. Pediatric Orphan Drugs Market Restraints
Table 17. Global Pediatric Orphan Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Pediatric Orphan Drugs Market Share by Players (2020-2025)
Table 19. Global Top Pediatric Orphan Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2024)
Table 20. Ranking of Global Top Pediatric Orphan Drugs Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Pediatric Orphan Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Pediatric Orphan Drugs, Headquarters and Area Served
Table 23. Global Key Players of Pediatric Orphan Drugs, Product and Application
Table 24. Global Key Players of Pediatric Orphan Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pediatric Orphan Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Pediatric Orphan Drugs Revenue Market Share by Type (2020-2025)
Table 28. Global Pediatric Orphan Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Pediatric Orphan Drugs Revenue Market Share by Type (2026-2031)
Table 30. Global Pediatric Orphan Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Pediatric Orphan Drugs Revenue Market Share by Application (2020-2025)
Table 32. Global Pediatric Orphan Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Pediatric Orphan Drugs Revenue Market Share by Application (2026-2031)
Table 34. North America Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Pediatric Orphan Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Pediatric Orphan Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Pediatric Orphan Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Pediatric Orphan Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Pediatric Orphan Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Pediatric Orphan Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Pediatric Orphan Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 49. Recordati SpA Company Details
Table 50. Recordati SpA Business Overview
Table 51. Recordati SpA Pediatric Orphan Drugs Product
Table 52. Recordati SpA Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 53. Recordati SpA Recent Development
Table 54. Novartis Company Details
Table 55. Novartis Business Overview
Table 56. Novartis Pediatric Orphan Drugs Product
Table 57. Novartis Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Celgene Company Details
Table 60. Celgene Business Overview
Table 61. Celgene Pediatric Orphan Drugs Product
Table 62. Celgene Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 63. Celgene Recent Development
Table 64. Abbvie Company Details
Table 65. Abbvie Business Overview
Table 66. Abbvie Pediatric Orphan Drugs Product
Table 67. Abbvie Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 68. Abbvie Recent Development
Table 69. Orpharma Company Details
Table 70. Orpharma Business Overview
Table 71. Orpharma Pediatric Orphan Drugs Product
Table 72. Orpharma Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 73. Orpharma Recent Development
Table 74. Amgen Company Details
Table 75. Amgen Business Overview
Table 76. Amgen Pediatric Orphan Drugs Product
Table 77. Amgen Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 78. Amgen Recent Development
Table 79. Amryt Pharma Plc. Company Details
Table 80. Amryt Pharma Plc. Business Overview
Table 81. Amryt Pharma Plc. Pediatric Orphan Drugs Product
Table 82. Amryt Pharma Plc. Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 83. Amryt Pharma Plc. Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Pediatric Orphan Drugs Product
Table 87. Johnson & Johnson Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. GSK Company Details
Table 90. GSK Business Overview
Table 91. GSK Pediatric Orphan Drugs Product
Table 92. GSK Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 93. GSK Recent Development
Table 94. Bristol-Myers Squibb Company Company Details
Table 95. Bristol-Myers Squibb Company Business Overview
Table 96. Bristol-Myers Squibb Company Pediatric Orphan Drugs Product
Table 97. Bristol-Myers Squibb Company Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 98. Bristol-Myers Squibb Company Recent Development
Table 99. Roche Holding Company Details
Table 100. Roche Holding Business Overview
Table 101. Roche Holding Pediatric Orphan Drugs Product
Table 102. Roche Holding Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 103. Roche Holding Recent Development
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Pediatric Orphan Drugs Product
Table 107. Pfizer Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 108. Pfizer Recent Development
Table 109. Sanofi Company Details
Table 110. Sanofi Business Overview
Table 111. Sanofi Pediatric Orphan Drugs Product
Table 112. Sanofi Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 113. Sanofi Recent Development
Table 114. Takeda Company Details
Table 115. Takeda Business Overview
Table 116. Takeda Pediatric Orphan Drugs Product
Table 117. Takeda Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 118. Takeda Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Pediatric Orphan Drugs Picture
Figure 2. Global Pediatric Orphan Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pediatric Orphan Drugs Market Share by Type: 2024 VS 2031
Figure 4. Oncology Drugs Features
Figure 5. Gastrointestinal Drugs Features
Figure 6. Neurology Drugs Features
Figure 7. Cardio-vascular Drugs Features
Figure 8. Others Features
Figure 9. Global Pediatric Orphan Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Pediatric Orphan Drugs Market Share by Application: 2024 VS 2031
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail pharmacies Case Studies
Figure 13. Others Case Studies
Figure 14. Pediatric Orphan Drugs Report Years Considered
Figure 15. Global Pediatric Orphan Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Pediatric Orphan Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Pediatric Orphan Drugs Market Share by Region: 2024 VS 2031
Figure 18. Global Pediatric Orphan Drugs Market Share by Players in 2024
Figure 19. Global Top Pediatric Orphan Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Pediatric Orphan Drugs Revenue in 2024
Figure 21. North America Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Pediatric Orphan Drugs Market Share by Country (2020-2031)
Figure 23. United States Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Pediatric Orphan Drugs Market Share by Country (2020-2031)
Figure 27. Germany Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Pediatric Orphan Drugs Market Share by Region (2020-2031)
Figure 35. China Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Pediatric Orphan Drugs Market Share by Country (2020-2031)
Figure 43. Mexico Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Pediatric Orphan Drugs Market Share by Country (2020-2031)
Figure 47. Turkey Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Recordati SpA Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 52. Celgene Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 53. Abbvie Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 54. Orpharma Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 55. Amgen Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 56. Amryt Pharma Plc. Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 57. Johnson & Johnson Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 58. GSK Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 59. Bristol-Myers Squibb Company Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 60. Roche Holding Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 61. Pfizer Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 62. Sanofi Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 63. Takeda Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Pediatric Orphan Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oncology Drugs
Table 3. Key Players of Gastrointestinal Drugs
Table 4. Key Players of Neurology Drugs
Table 5. Key Players of Cardio-vascular Drugs
Table 6. Key Players of Others
Table 7. Global Pediatric Orphan Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pediatric Orphan Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Pediatric Orphan Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Pediatric Orphan Drugs Market Share by Region (2020-2025)
Table 11. Global Pediatric Orphan Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Pediatric Orphan Drugs Market Share by Region (2026-2031)
Table 13. Pediatric Orphan Drugs Market Trends
Table 14. Pediatric Orphan Drugs Market Drivers
Table 15. Pediatric Orphan Drugs Market Challenges
Table 16. Pediatric Orphan Drugs Market Restraints
Table 17. Global Pediatric Orphan Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Pediatric Orphan Drugs Market Share by Players (2020-2025)
Table 19. Global Top Pediatric Orphan Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2024)
Table 20. Ranking of Global Top Pediatric Orphan Drugs Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Pediatric Orphan Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Pediatric Orphan Drugs, Headquarters and Area Served
Table 23. Global Key Players of Pediatric Orphan Drugs, Product and Application
Table 24. Global Key Players of Pediatric Orphan Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pediatric Orphan Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Pediatric Orphan Drugs Revenue Market Share by Type (2020-2025)
Table 28. Global Pediatric Orphan Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Pediatric Orphan Drugs Revenue Market Share by Type (2026-2031)
Table 30. Global Pediatric Orphan Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Pediatric Orphan Drugs Revenue Market Share by Application (2020-2025)
Table 32. Global Pediatric Orphan Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Pediatric Orphan Drugs Revenue Market Share by Application (2026-2031)
Table 34. North America Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Pediatric Orphan Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Pediatric Orphan Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Pediatric Orphan Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Pediatric Orphan Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Pediatric Orphan Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Pediatric Orphan Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Pediatric Orphan Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Pediatric Orphan Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 49. Recordati SpA Company Details
Table 50. Recordati SpA Business Overview
Table 51. Recordati SpA Pediatric Orphan Drugs Product
Table 52. Recordati SpA Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 53. Recordati SpA Recent Development
Table 54. Novartis Company Details
Table 55. Novartis Business Overview
Table 56. Novartis Pediatric Orphan Drugs Product
Table 57. Novartis Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Celgene Company Details
Table 60. Celgene Business Overview
Table 61. Celgene Pediatric Orphan Drugs Product
Table 62. Celgene Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 63. Celgene Recent Development
Table 64. Abbvie Company Details
Table 65. Abbvie Business Overview
Table 66. Abbvie Pediatric Orphan Drugs Product
Table 67. Abbvie Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 68. Abbvie Recent Development
Table 69. Orpharma Company Details
Table 70. Orpharma Business Overview
Table 71. Orpharma Pediatric Orphan Drugs Product
Table 72. Orpharma Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 73. Orpharma Recent Development
Table 74. Amgen Company Details
Table 75. Amgen Business Overview
Table 76. Amgen Pediatric Orphan Drugs Product
Table 77. Amgen Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 78. Amgen Recent Development
Table 79. Amryt Pharma Plc. Company Details
Table 80. Amryt Pharma Plc. Business Overview
Table 81. Amryt Pharma Plc. Pediatric Orphan Drugs Product
Table 82. Amryt Pharma Plc. Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 83. Amryt Pharma Plc. Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Pediatric Orphan Drugs Product
Table 87. Johnson & Johnson Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. GSK Company Details
Table 90. GSK Business Overview
Table 91. GSK Pediatric Orphan Drugs Product
Table 92. GSK Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 93. GSK Recent Development
Table 94. Bristol-Myers Squibb Company Company Details
Table 95. Bristol-Myers Squibb Company Business Overview
Table 96. Bristol-Myers Squibb Company Pediatric Orphan Drugs Product
Table 97. Bristol-Myers Squibb Company Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 98. Bristol-Myers Squibb Company Recent Development
Table 99. Roche Holding Company Details
Table 100. Roche Holding Business Overview
Table 101. Roche Holding Pediatric Orphan Drugs Product
Table 102. Roche Holding Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 103. Roche Holding Recent Development
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Pediatric Orphan Drugs Product
Table 107. Pfizer Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 108. Pfizer Recent Development
Table 109. Sanofi Company Details
Table 110. Sanofi Business Overview
Table 111. Sanofi Pediatric Orphan Drugs Product
Table 112. Sanofi Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 113. Sanofi Recent Development
Table 114. Takeda Company Details
Table 115. Takeda Business Overview
Table 116. Takeda Pediatric Orphan Drugs Product
Table 117. Takeda Revenue in Pediatric Orphan Drugs Business (2020-2025) & (US$ Million)
Table 118. Takeda Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Pediatric Orphan Drugs Picture
Figure 2. Global Pediatric Orphan Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pediatric Orphan Drugs Market Share by Type: 2024 VS 2031
Figure 4. Oncology Drugs Features
Figure 5. Gastrointestinal Drugs Features
Figure 6. Neurology Drugs Features
Figure 7. Cardio-vascular Drugs Features
Figure 8. Others Features
Figure 9. Global Pediatric Orphan Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Pediatric Orphan Drugs Market Share by Application: 2024 VS 2031
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail pharmacies Case Studies
Figure 13. Others Case Studies
Figure 14. Pediatric Orphan Drugs Report Years Considered
Figure 15. Global Pediatric Orphan Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Pediatric Orphan Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Pediatric Orphan Drugs Market Share by Region: 2024 VS 2031
Figure 18. Global Pediatric Orphan Drugs Market Share by Players in 2024
Figure 19. Global Top Pediatric Orphan Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Pediatric Orphan Drugs Revenue in 2024
Figure 21. North America Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Pediatric Orphan Drugs Market Share by Country (2020-2031)
Figure 23. United States Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Pediatric Orphan Drugs Market Share by Country (2020-2031)
Figure 27. Germany Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Pediatric Orphan Drugs Market Share by Region (2020-2031)
Figure 35. China Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Pediatric Orphan Drugs Market Share by Country (2020-2031)
Figure 43. Mexico Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Pediatric Orphan Drugs Market Share by Country (2020-2031)
Figure 47. Turkey Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Pediatric Orphan Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Recordati SpA Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 52. Celgene Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 53. Abbvie Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 54. Orpharma Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 55. Amgen Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 56. Amryt Pharma Plc. Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 57. Johnson & Johnson Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 58. GSK Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 59. Bristol-Myers Squibb Company Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 60. Roche Holding Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 61. Pfizer Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 62. Sanofi Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 63. Takeda Revenue Growth Rate in Pediatric Orphan Drugs Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Multi-Channel Temperature Controllers Market Research Report 2025
Mar 14, 25
Global Waterproof Action Cameras Market Research Report 2025
Mar 14, 25
Global Infrared IP Cameras Market Research Report 2025
Mar 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232